Johnson & Johnson (JNJ) Non Operating Income (2009 - 2026)

Johnson & Johnson (JNJ) posted Non Operating Income of -$294.0 million for Q1 2026, up 39.13% sequentially from -$483.0 million in Q4 2025, and down 104.02% YoY from $7.3 billion in Q1 2025.

Johnson & Johnson (JNJ) Non Operating Income (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Non Operating Income data on file, last reported at -$294.0 million in Q1 2026.

  • Quarterly Non Operating Income fell 104.02% year-over-year to -$294.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$406.0 million (down 108.07% YoY) and the FY2025 annual result came in at $7.2 billion, up 253.58% from the prior year.
  • Non Operating Income advanced to -$294.0 million in Q1 2026 per JNJ's latest filing, from -$483.0 million in the prior quarter.
  • The five-year high for Non Operating Income was $7.3 billion in Q1 2025, with the low at -$6.9 billion in Q2 2023.
  • Average Non Operating Income over 5 years is -$302.4 million, with a median of -$273.0 million recorded in 2022.
  • Year-over-year, Non Operating Income tumbled 6903.92% in 2023 and soared 404.53% in 2025.
  • Johnson & Johnson's Non Operating Income stood at -$226.0 million in 2022, then surged by 286.28% to $421.0 million in 2023, then sank by 61.76% to $161.0 million in 2024, then sank by 400.0% to -$483.0 million in 2025, then surged by 39.13% to -$294.0 million in 2026.
  • Business Quant data shows JNJ's Non Operating Income at -$294.0 million in Q1 2026, -$483.0 million in Q4 2025, and $478.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -65.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -294.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -2.31 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.49 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -138.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 235.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -861.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -294.00 Mn
Dec 28, 2025 -483.00 Mn
Sep 28, 2025 478.00 Mn
Jun 29, 2025 -107.00 Mn
Mar 30, 2025 7.32 Bn
Dec 29, 2024 161.00 Mn
Sep 29, 2024 -1.80 Bn
Jun 30, 2024 -653.00 Mn
Mar 31, 2024 -2.40 Bn
Dec 31, 2023 421.00 Mn
Oct 1, 2023 -499.00 Mn
Jul 2, 2023 384.00 Mn
Apr 2, 2023 -6.94 Bn
Jan 1, 2023 -330.00 Mn
Oct 2, 2022 -226.00 Mn
Jul 3, 2022 -273.00 Mn
Apr 3, 2022 102.00 Mn
Oct 3, 2021 -1.85 Bn
Jul 4, 2021 488.00 Mn
Apr 4, 2021 882.00 Mn